This podcast episode explores the challenges and opportunities facing consumer-focused companies in the wake of the pandemic. It analyzes Chewy's recent performance and market reaction, highlights Dollar General's potential turnaround strategy, and discusses Dexcom's journey to establish itself as an industry leader in CGM devices. The episode also examines the impact of weight loss drugs on the future of CGM products and explores the role of DexCom in the future of diabetes management and healthcare.
